Correction: Factors associated with longer brain metastasis-free survival in limited-disease small-cell lung cancer who underwent concurrent chemoradiotherapy, a retrospective analysis | Synapse
March 3, 2026Open Access
Correction: Factors associated with longer brain metastasis-free survival in limited-disease small-cell lung cancer who underwent concurrent chemoradiotherapy, a retrospective analysis
Key Points
Longer brain metastasis-free survival is linked to specific factors in small-cell lung cancer patients.
Key metric highlights a correlation between treatment strategies and survival timelines.
Retrospective analysis showcases survival outcomes among those receiving concurrent chemoradiotherapy.
Implications suggest potential for improved treatment approaches based on identified factors.
Abstract
This corrects the article DOI: 10.3389/fonc.2025.1739788..